top of page
Study Finds Minnesota Hospitals Channel 340B Drug Profits into Investments Instead of Patient Care
MILWAUKEE ( March 26, 2026) -- Hospitals in Minnesota participating in the federal 340B Drug Pricing Program are directing tens of millions of dollars from the program into financial investments rather than expanding care for vulnerable patients, according to a new analysis by Dr. Lisa Grabert, a health policy researcher at Marquette University. On average, Minnesota hospitals in the program invested $52.2 million in stocks and bonds, more than three times the $14.2 millio
Mar 26
Study: New York Hospitals Using Federal Drug Discount Profits for Investments, Not Patient Care
MILWAUKEE (March 19, 2026) -- New York hospitals participating in the federal 340B Drug Discount Program are generating substantially higher revenues and directing large sums into Wall Street investments rather than expanding care for vulnerable patients, according to a new analysis by Dr. Lisa Grabert, a health policy researcher at Marquette University and former senior House Ways and Means Committee aide. The study finds that New York's 340B hospitals invested 42% more reve
Mar 19
Study: Illinois Hospitals Using Federal Drug Discount Profits to Boost Investments
MILWAUKEE (March 12, 2026) -- Illinois hospitals participating in the federal 340B Drug Pricing Program are generating significantly higher revenues and investing far more money in stocks and bonds than other hospitals, according to an analysis published today by health policy researcher Dr. Lisa Grabert. The study finds that Illinois hospitals participating in the program reported 41% higher patient revenue than non-340B hospitals and invested 119% more revenue in financ
Mar 12
New York Times: Hospitals Cater to ‘Transplant Tourists’ as U.S. Patients Wait for Organs
Irene Gebrael was an Arabic interpreter at Montefiore when, she said, she had an idea: If the hospital recruited international patients, it could serve a broader population – and make a lot of money. “The hospital is always happy about the international rates,” Ms. Gebrael said in an interview. “Trust me.” In 2013, she said, she persuaded hospital executives to start an international office. It was good timing for the transplant program. For decades, hospitals that gave mo
Feb 10
Virginia 340B Health Center Under Fire for Predatory Debt Collection
Nearly one third of working-age adults in the U.S. are in medical debt, according to the most recent data from The Commonwealth Fund . Of those adults with medical debt, 40% have had to cut back on basic necessities to pay back their debt. Considering this rising issue, ProPublica reported on the medical debt collection practices of non-profit hospitals and clinics across the country. One community health center in Virginia, which participates in the 340B drug discount pro
Feb 3
Study: Virginia Hospitals Use Federal Drug Discount Profits for Investments, Not Patient Care
WASHINGTON, D.C. (Jan. 29, 2026) -- Virginia's 340B hospitals invested nearly five times more in stocks and bonds than non-340B hospitals, netting millions off the federal drug discount program, according to a new analysis by Dr. Lisa Grabert, a health policy researcher at Marquette University and former senior House Ways and Means Committee aide. "The 340B program isn't working for the Virginia families it was designed to help," Grabert said. "Too many of the state's disprop
Jan 29
From Safety-Net Hospitals to Stock Portfolio: How Hospitals Capitalize on 340B
The 340B program was supposed to help hospitals care for low-income and uninsured patients. But over time, it’s turned into something very different. Instead of putting patients first, many hospitals now treat 340B as a major revenue generator – often with little benefit to the communities it was meant to support. An analysis conducted by Magnolia Market Access reveals that the number of disproportionate share hospitals (DSHs) participating in 340B program has jumped 565% fr
Dec 1, 2025
Are Michigan hospitals putting finances ahead of patients?
By: Lisa M. Grabert, MPH, Visiting Professor of Research, Marquette University Hospitals across Michigan are exploiting a little-known federal program to squeeze millions of dollars from the state's poorest patients. Congress created the 340B Drug Pricing Program in 1992. It allows certain hospitals to purchase medicines from drug companies at substantial, mandatory discounts. Congress aimed for hospitals to reinvest these savings in patient care.
Dec 1, 2025
New Research Reveals Michigan Hospitals Are Exploiting a Program Meant to Make Medicines Affordable for Low-Income Patients
MILWAUKEE, WIS. (Nov. 18, 2025) -- New research reveals that Michigan hospitals are making significant profits off a program designed to help low-income patients access affordable medicine without delivering community benefits. That's among the key findings of an analysis conducted by Dr. Lisa Grabert , visiting research professor of health policy at Marquette University and former senior aide to the House Ways and Means Committee. “Our analysis exposes a system that is
Nov 18, 2025
CARH Letter to Senate HELP Committee Ahead of 340B Hearing
October 22, 2025 The Honorable Bill Cassidy, Chair The Honorable Bernie Sanders, Ranking Member Senate Committee on Health, Education, Labor, and Pensions 428 Senate Dirksen Office Building Washington, DC 20510 Dear Chair Cassidy, Ranking Member Sanders, and Members of the Committee: On behalf of Community Action for Responsible Hospitals (CARH), representing the interests of workers, faith leaders, healthcare providers, and patient advocates, we appreciate the Committee’s a
Oct 22, 2025
bottom of page